Methionine sulfoxide reductase A (MsrA) is an antioxidant repair enzyme which reduces oxidized methionine to methionine. Since oxidation of methionine in proteins impairs their function, an absence of MsrA leads to abnormalities in different organisms, including alterations in the adherence patterns and in vivo survival of certain pathogenic bacteria. To understand the role of MsrA in intracellular survival of bacteria, we disrupted the gene encoding MsrA in Mycobacterium smegmatis through homologous recombination. The msrA mutant strain of M. smegmatis exhibited significantly reduced intracellular survival in murine J774A.1 macrophages compared to the survival of its wild-type counterpart. Furthermore, immunofluorescence and immnunoblotting of phagosomes containing M. smegmatis strains revealed that the phagosomes with the msrA mutant strain acquired both p67 phox of phagocyte NADPH oxidase and inducible nitric oxide synthase much earlier than the phagosomes with the wild-type strain. In addition, the msrA mutant strain of M. smegmatis was observed to be more sensitive to hydroperoxides than the wild-type strain was in vitro. These results suggest that MsrA plays an important role in both extracellular and intracellular survival of M. smegmatis.Although mononuclear phagocytes are specially equipped to produce superoxide (O 2 Ϫ˙) radicals through the NADPH oxidase (phox) complex (32, 35), most living cells also generate superoxide as a by-product of normal aerobic metabolism. This occurs due to incomplete reduction of oxygen at the level of the cytochrome oxidase system, which accounts for approximately 4% of the oxygen that enters into this system (50). Superoxide reacts with a variety of organic and inorganic compounds and generates toxic reactive oxygen intermediates (ROI), such as H 2 O 2 , HO˙Ϫ, HOCl, and OONO˙Ϫ (25, 52). Toxic ROI oxidize cellular macromolecules like proteins, lipids, and nucleic acids, which accelerates aging processes and disease in living organisms (4).In proteins, oxidation occurs mainly at the sulfur-containing amino acids cysteine and methionine (40). Oxidation of methionine leads to the formation of methionine sulfoxide, and methionine sulfoxide reductase A (MsrA), which was first identified in Escherichia coli (5), has long been implicated in the reduction of methionine sulfoxide in proteins. However, recent studies have demonstrated that oxidation of methionine leads to two stereomeric forms of methionine sulfoxide, methionione S-sulfoxide and methionine R-sulfoxide (21, 50); the reduction of these compounds is catalyzed by MsrA and MsrB, respectively, (21, 30). Analysis of the sequences of different genomes has revealed that the genes coding for both MsrA and MsrB are present in almost all living organisms, from prokaryotes to humans (11,18,21). Interestingly, however, MsrB from different organisms shows no sequence identity with MsrA (17). Also, in contrast to MsrA, MsrB requires the metal cofactor selenium or zinc (18) for reactivity.Since the oxidation of methionine in protein...
Biochemical, structural, and functional properties of Rab5 wild-type (WT) protein were compared with those of Q79L and N133I mutants. The detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate increased guanine nucleotide binding to Rab5 WT approximately 10-fold. The single-step catalytic rate of Rab5 WT exceeded that of Q79L 12.2-fold, but the steady-state GTPase rate was only 2.8-fold greater because GDP dissociation was rate-limiting and GDP dissociation was 3.6-fold slower than for Q79L. In contrast, dissociation rates of GTP were indistinguishable. Binding to Rab5 N133I was not detectable. GTP protected Rab5 WT and Q79L from any apparent proteolysis by trypsin. A 20-kDa fragment was the major product of digestion in the presence of GDP, and 12- and 8-kDa fragments were the major products in the absence of added guanine nucleotides. Rab5 N133I underwent no apparent proteolysis with 10 mM GTP or GDP, suggesting a "triphosphate" conformation may be induced in Rab5 N133I by either GTP or GDP. Partially geranylgeranylated Rab5 WT stimulated endosome fusion in vitro, whereas unmodified Rab5 WT did not. Processed Rab5 Q79L failed to inhibit endosome fusion, and Rab5 N133I could not be geranylgeranylated. These findings identify biochemical and structural features of Rab5 proteins, providing data for the interpretation of functional assays.
Complement C5-deficient (C5−/−) macrophages derived from B.10 congenic mice were found to be defective in killing intracellular Mycobacterium tuberculosis (MTB). They were bacteriostatic after activation with IFN-γ alone but bactericidal in the combined presence of IFN-γ and C5-derived C5a anaphylatoxin that was deficient among these macrophages. Reduced killing correlated with a decreased production of reactive oxygen species (ROS) in the C5−/− macrophages measured using fluorescent probes. Furthermore, a lack of colocalization of p47phox protein of the NADPH oxidase (phox) complex with GFP-expressing MTB (gfpMTB) indicated a defective assembly of the phox complex on phagosomes. Reconstitution with C5a, a known ROS activator, enhanced the assembly of phox complex on the phagosomes as well as the production of ROS that inhibited the growth of MTB. Protein kinase C (PKC) isoforms are involved in the phosphorylation and translocation of p47phox onto bacterial phagosomes. Western blot analysis demonstrated a defective phosphorylation of PKC (α, β, δ) and PKC-ζ in the cytosol of C5−/− macrophages compared with C5 intact (C5+/+) macrophages. Furthermore, in situ fluorescent labeling of phagosomes indicated that PKC-β and PKC-ζ were the isoforms that are not phosphorylated in C5−/− macrophages. Because Fc receptor-mediated phox assembly was normal in both C5−/− and C5+/+ macrophages, the defect in phox assembly around MTB phagosomes was specific to C5 deficiency. Reduced bactericidal function of C5−/− macrophages thus appears to be due to a defective assembly and production of ROS that prevents effective killing of intracellular MTB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.